Trial record 1 of 32 for:    font
Previous Study | Return to List | Next Study

Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial (FONT II)

This study has been completed.
University of Michigan
The Cleveland Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by (Responsible Party):
New York University School of Medicine Identifier:
First received: December 22, 2008
Last updated: April 10, 2014
Last verified: April 2014